| CG106 |
Barrett's oesophagus - ablative therapy (CG106) |
|
-
-
Ablative therapy for the treatment of Barrett's oesophagus
This clinical guideline offers evidence-based advice on the care and treatment of adults having ablative therapy to treat Barrett’s oesophagus with high-grade dysplasia or with intramucosal cancer. It is the full guideline and contains all the recommendations, details of how they were developed, and reviews of the evidence they were based on. Barrett’s oesophagus develops when stomach acid or bile repeatedly leaks upwards and damages the lining of the oesophagus.
-
Other information
How this guidance was produced
Background information
This page was last updated: 18 January 2012
-
-
Guideline formats
-
Implementation tools and resources
See this guidance in practice
Patient
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
NICE Guideline
The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.
Full Guideline
The published full clinical guideline for specialists with background, evidence, recommendations and methods used.
